Drugmaker halts search for new knee pain pill

NCT ID NCT05838742

Terminated Symptom relief Sponsor: GlaxoSmithKline Source: ClinicalTrials.gov ↗

Summary

This study aimed to find the best dose of an experimental drug, GSK3858279, to relieve moderate to severe pain from knee osteoarthritis. It involved 314 adults aged 40-80 and compared different doses of the drug against a placebo over 12 weeks. The trial was terminated early, and its main goal was to see how well the drug reduced daily knee pain and improved physical function.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

GSK Investigational Site

Cerritos, California, 90703, United States
GSK Investigational Site

Huntington Beach, California, 92647, United States
GSK Investigational Site

Santa Clara, California, 95054, United States
GSK Investigational Site

Cooper City, Florida, 33024, United States
GSK Investigational Site

Cutler Bay, Florida, 33189, United States
GSK Investigational Site

Miami, Florida, 33173, United States
GSK Investigational Site

Miami, Florida, 33185, United States
GSK Investigational Site

Wichita, Kansas, 67207, United States
GSK Investigational Site

Louisville, Kentucky, 40213, United States
GSK Investigational Site

New Orleans, Louisiana, 70115, United States
GSK Investigational Site

Henderson, Nevada, 89052, United States
GSK Investigational Site

Williamsville, New York, 14221, United States
GSK Investigational Site

Greensboro, North Carolina, 27410, United States
GSK Investigational Site

Duncansville, Pennsylvania, 16635, United States
GSK Investigational Site

Charlottesville, Virginia, 22911, United States
GSK Investigational Site

Buenos Aires, C1128AAF, Argentina
GSK Investigational Site

Buenos Aires-San Isidro, 1643, Argentina
GSK Investigational Site

Ciudad Autonoma Buenos Aires, C1417, Argentina
GSK Investigational Site

Ciudad AutOnoma de Buenos Aire, 1118, Argentina
GSK Investigational Site

Ciudad Autonoma de Buenos Aire, C1046AAQ, Argentina
GSK Investigational Site

Mar del Plata, B7600FYK, Argentina
GSK Investigational Site

Botany, New South Wales, 2019, Australia
GSK Investigational Site

Kotara, New South Wales, 2289, Australia
GSK Investigational Site

Sydney, New South Wales, 2010, Australia
GSK Investigational Site

Camberwell, Victoria, 3124, Australia
GSK Investigational Site

Victoria, British Columbia, V8V 4A1, Canada
GSK Investigational Site

Brampton, Ontario, L6T 0G1, Canada
GSK Investigational Site

Guelph, Ontario, N1H 1B1, Canada
GSK Investigational Site

Sarnia, Ontario, N7T 4X3, Canada
GSK Investigational Site

Toronto, Ontario, M5T 2S8, Canada
GSK Investigational Site

Toronto, Ontario, M9V 4B4, Canada
GSK Investigational Site

Winchester, Ontario, K0C 2K0, Canada
GSK Investigational Site

Joliette, Quebec, J6E 6A9, Canada
GSK Investigational Site

Sherbrooke, Quebec, J1L 0H8, Canada
GSK Investigational Site

Trois-Rivières, Quebec, G9A 3X2, Canada
GSK Investigational Site

Beijing, 100083, China
GSK Investigational Site

Beijing, 100730, China
GSK Investigational Site

Changchun, 130021, China
GSK Investigational Site

Chengdu, 610041, China
GSK Investigational Site

Guangzhou, 510000, China
GSK Investigational Site

Hohhot, 010017, China
GSK Investigational Site

Nanjing, 210009, China
GSK Investigational Site

Shanghai, 200011, China
GSK Investigational Site

Shanghai, 200040, China
GSK Investigational Site

Shanghai, 200065, China
GSK Investigational Site

Shenyang, 110022, China
GSK Investigational Site

Shijiazhuang, 050051, China
GSK Investigational Site

Tianjin, 300192, China
GSK Investigational Site

Zhuzhou, 412007, China
GSK Investigational Site

Dax, 40107, France
GSK Investigational Site

La Roche-sur-Yon, 85925, France
GSK Investigational Site

La Rochelle, 17019, France
GSK Investigational Site

Montpellier, 34000, France
GSK Investigational Site

Paris, 75012, France
GSK Investigational Site

Berlin, 10117, Germany
GSK Investigational Site

Hamburg, 20095, Germany
GSK Investigational Site

Hamburg, 22415, Germany
GSK Investigational Site

Magdeburg, 39120, Germany
GSK Investigational Site

Fukuoka, 834-0115, Japan
GSK Investigational Site

Ibaraki, 300-1234, Japan
GSK Investigational Site

Ibaraki, 300-1253, Japan
GSK Investigational Site

Nagano, 390-8601, Japan
GSK Investigational Site

Nagano, 395-8505, Japan
GSK Investigational Site

Osaka, 543-0027, Japan
GSK Investigational Site

Saitama, 330-0074, Japan
GSK Investigational Site

Shimane, 693-8501, Japan
GSK Investigational Site

Tokyo, 103-0027, Japan
GSK Investigational Site

Tokyo, 104-0031, Japan
GSK Investigational Site

Tokyo, 113-8431, Japan
GSK Investigational Site

Chihuahua City, 31000, Mexico
GSK Investigational Site

Guadalajara, 44650, Mexico
GSK Investigational Site

Mexicali, 21200, Mexico
GSK Investigational Site

Mérida, CP 97070, Mexico
GSK Investigational Site

Torreón, 27000, Mexico
GSK Investigational Site

Cape Town, 7130, South Africa
GSK Investigational Site

Cape Town, 7405, South Africa
GSK Investigational Site

Gauteng, 1619, South Africa
GSK Investigational Site

Johannesburg, 2113, South Africa
GSK Investigational Site

Stellenbosch, 7600, South Africa
GSK Investigational Site

Seoul, 03080, South Korea
GSK Investigational Site

Seoul, 06973, South Korea
GSK Investigational Site

Seoul, 07441, South Korea
GSK Investigational Site

A Coruña, 15006, Spain
GSK Investigational Site

Barcelona, 08430, Spain
GSK Investigational Site

Barcelona, 08540, Spain
GSK Investigational Site

Madrid, 28046, Spain
GSK Investigational Site

Santander, 39008, Spain
GSK Investigational Site

Santiago de Compostela, 15702, Spain
GSK Investigational Site

Seville, 41014, Spain
GSK Investigational Site

Blackpool, FY2 0JH, United Kingdom
GSK Investigational Site

Cannock, WS11 0BN, United Kingdom
GSK Investigational Site

London, EN5 3DJ, United Kingdom
GSK Investigational Site

Manchester, M13 9NQ, United Kingdom

Conditions

Explore the condition pages connected to this study.

OSTEOARTHRITIS, KNEE PAIN